ro5093151
Showing 1 - 5 of 5
Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD Trial in Austria, Germany (Placebo, RO5093151)
Completed
- Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD
- Placebo
- RO5093151
-
Wien, Austria
- +3 more
Nov 1, 2016
Healthy Volunteer Trial in Merritt Island (RO5093151, atazanavir, ketoconazole)
Completed
- Healthy Volunteer
- RO5093151
- +4 more
-
Merritt Island, Florida(unnamed)
Nov 1, 2016
Hypertension, Glaucoma, Open-Angle Trial in Worldwide (Placebo, RO5093151)
Completed
- Hypertension, Glaucoma, Open-Angle
- Placebo
- RO5093151
-
Morrow, Georgia
- +11 more
Nov 1, 2016
Diabetes Type 2 Trial in Austria, Germany, United States (Placebo, RO5027838, RO5093151)
Completed
- Diabetes Mellitus Type 2
- Placebo
- +2 more
-
Chula Vista, California
- +4 more
Jul 26, 2016